- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Thyrotropin Receptor Blocking Antibodies ; volume:50 ; number:12 ; year:2018 ; pages:853-862
Hormone and metabolic research ; 50, Heft 12 (2018), 853-862
- Contributor
-
Diana, Tanja
Olivo, Paul D.
Kahaly, George J.
- DOI
-
10.1055/a-0723-9023
- URN
-
urn:nbn:de:101:1-2019042107524555156549
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Diana, Tanja
- Olivo, Paul D.
- Kahaly, George J.
Other Objects (12)
Correction to: Thyrotropin receptor antibodies and Graves’ orbitopathy
Thyrotropin
Prevalence of Thyrotropin Receptor Antibodies and Clinical Profile of Patients with Alopecia Areata: A Cross-Sectional Study
Thyrotropin-Ampullen
PD‐1 blocking antibodies moonlighting as killers
Graves’ Disease Mechanisms: The Role of Stimulating, Blocking, and Cleavage Region TSH Receptor Antibodies
Comparison of three methods for determining anti-thyrotropin receptor antibodies (TRAb) for diagnosis of Graves’ disease: a clinical validation
Molecular basis for the activation of thyrotropin-releasing hormone receptor
Amniotic fluid thyrotropin (TSH) following maternal administration of thyrotropin releasing hormone
Blocking Plasmodium development in the mosquitoes by human antibodies
Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies
Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis
Correction to: Thyrotropin receptor antibodies and Graves’ orbitopathy
Thyrotropin
Prevalence of Thyrotropin Receptor Antibodies and Clinical Profile of Patients with Alopecia Areata: A Cross-Sectional Study
Thyrotropin-Ampullen
PD‐1 blocking antibodies moonlighting as killers
Graves’ Disease Mechanisms: The Role of Stimulating, Blocking, and Cleavage Region TSH Receptor Antibodies
Comparison of three methods for determining anti-thyrotropin receptor antibodies (TRAb) for diagnosis of Graves’ disease: a clinical validation
Molecular basis for the activation of thyrotropin-releasing hormone receptor
Amniotic fluid thyrotropin (TSH) following maternal administration of thyrotropin releasing hormone
Blocking Plasmodium development in the mosquitoes by human antibodies
Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies
Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis
Correction to: Thyrotropin receptor antibodies and Graves’ orbitopathy
Thyrotropin
Prevalence of Thyrotropin Receptor Antibodies and Clinical Profile of Patients with Alopecia Areata: A Cross-Sectional Study
Thyrotropin-Ampullen
PD‐1 blocking antibodies moonlighting as killers
Graves’ Disease Mechanisms: The Role of Stimulating, Blocking, and Cleavage Region TSH Receptor Antibodies
Comparison of three methods for determining anti-thyrotropin receptor antibodies (TRAb) for diagnosis of Graves’ disease: a clinical validation
Molecular basis for the activation of thyrotropin-releasing hormone receptor
Amniotic fluid thyrotropin (TSH) following maternal administration of thyrotropin releasing hormone
Blocking Plasmodium development in the mosquitoes by human antibodies
Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies